1. Home
  2. FXNC vs AGEN Comparison

FXNC vs AGEN Comparison

Compare FXNC & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First National Corporation

FXNC

First National Corporation

HOLD

Current Price

$29.40

Market Cap

288.4M

Sector

Finance

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$8.40

Market Cap

274.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXNC
AGEN
Founded
1907
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.4M
274.8M
IPO Year
2012
1999

Fundamental Metrics

Financial Performance
Metric
FXNC
AGEN
Price
$29.40
$8.40
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
17.8K
846.4K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
2.43%
N/A
EPS Growth
96.00
100.00
EPS
1.17
0.96
Revenue
$7,717,000.00
$42,877,086.00
Revenue This Year
$12.21
$107.63
Revenue Next Year
$2.93
N/A
P/E Ratio
$26.03
$9.06
Revenue Growth
7.40
89.95
52 Week Low
$21.59
$2.71
52 Week High
$33.24
$8.85

Technical Indicators

Market Signals
Indicator
FXNC
AGEN
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
FXNC
AGEN

About FXNC First National Corporation

First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: